These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 24561734)

  • 1. Predictors of contrast-induced nephropathy in chronic total occlusion percutaneous coronary intervention.
    Lin YS; Fang HY; Hussein H; Fang CY; Chen YL; Hsueh SK; Cheng CI; Yang CH; Chen CJ; Hang CL; Yip HK; Wu CJ
    EuroIntervention; 2014 Feb; 9(10):1173-80. PubMed ID: 24561734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.
    Wang Y; Zhao HW; Zhang XJ; Chen BJ; Yu GN; Hou AJ; Luan B
    BMC Cardiovasc Disord; 2019 Mar; 19(1):74. PubMed ID: 30922230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease.
    Demir OM; Lombardo F; Poletti E; Laricchia A; Beneduce A; Maccagni D; Slavich M; Giannini F; Carlino M; Margonato A; Cappelletti A; Colombo A; Azzalini L
    Am J Cardiol; 2018 Dec; 122(11):1837-1842. PubMed ID: 30292337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictors of successful percutaneous coronary intervention in ostial left anterior descending artery chronic total occlusion.
    Fang HY; Lu SY; Lee WC; Lin YS; Cheng CI; Chen CJ; Yang CH; Yip HK; Hang CL; Fang CY; Wu CJ
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):E30-7. PubMed ID: 24740864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Clinical and Angiographic Scoring System to Predict the Probability of Successful First-Attempt Percutaneous Coronary Intervention in Patients With Total Chronic Coronary Occlusion.
    Alessandrino G; Chevalier B; Lefèvre T; Sanguineti F; Garot P; Unterseeh T; Hovasse T; Morice MC; Louvard Y
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1540-8. PubMed ID: 26493246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and predictors of contrast-induced nephropathy after angioplasty for chronic total occlusions.
    Aguiar-Souto P; Ferrante G; Del Furia F; Barlis P; Khurana R; Di Mario C
    Int J Cardiol; 2010 Feb; 139(1):68-74. PubMed ID: 19056138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, angiographic, and procedural predictors of periprocedural complications during chronic total occlusion percutaneous coronary intervention.
    Patel VG; Michael TT; Mogabgab O; Fuh E; Banerjee A; Brayton KM; Cipher DJ; Abdullah SM; Brilakis ES
    J Invasive Cardiol; 2014 Mar; 26(3):100-5. PubMed ID: 24610502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes.
    Zeng JF; Chen SQ; Ye JF; Chen Y; Lei L; Liu XQ; Liu Y; Wang Y; Lin JJ; Chen JY
    Clin Exp Nephrol; 2019 Jul; 23(7):969-981. PubMed ID: 31049747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies.
    Patel VG; Brayton KM; Tamayo A; Mogabgab O; Michael TT; Lo N; Alomar M; Shorrock D; Cipher D; Abdullah S; Banerjee S; Brilakis ES
    JACC Cardiovasc Interv; 2013 Feb; 6(2):128-36. PubMed ID: 23352817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-induced nephropathy following chronic total occlusion percutaneous coronary intervention in patients with chronic kidney disease.
    Liu YH; Liu Y; Tan N; Chen JY; Zhou YL; Luo JF; Yu DQ; Li LW; Li HL; Ye P; Ran P
    Eur Radiol; 2015 Aug; 25(8):2274-81. PubMed ID: 25981215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
    Worasuwannarak S; Pornratanarangsi S
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
    Chong E; Shen L; Poh KK; Tan HC
    Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention.
    Kandula P; Shah R; Singh N; Markwell SJ; Bhensdadia N; Navaneethan SD
    Nephrology (Carlton); 2010 Mar; 15(2):165-70. PubMed ID: 20470274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Novel Scoring System for Predicting Technical Success of Chronic Total Occlusion Percutaneous Coronary Interventions: The PROGRESS CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) Score.
    Christopoulos G; Kandzari DE; Yeh RW; Jaffer FA; Karmpaliotis D; Wyman MR; Alaswad K; Lombardi W; Grantham JA; Moses J; Christakopoulos G; Tarar MNJ; Rangan BV; Lembo N; Garcia S; Cipher D; Thompson CA; Banerjee S; Brilakis ES
    JACC Cardiovasc Interv; 2016 Jan; 9(1):1-9. PubMed ID: 26762904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.
    Chanin JM; Yang DC; Haider MA; Swaminathan RV; Kim LK; Charitakis K; Tanoue M; Minutello RM; Gade CL; Singh HS; Bergman G; Wong SC; Feldman DN
    J Invasive Cardiol; 2015 Nov; 27(11):490-6. PubMed ID: 25999136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female gender and contrast-induced nephropathy in primary percutaneous intervention for ST-segment elevation myocardial infarction.
    Lucreziotti S; Centola M; Salerno-Uriarte D; Ponticelli G; Battezzati PM; Castini D; Sponzilli C; Lombardi F
    Int J Cardiol; 2014 Jun; 174(1):37-42. PubMed ID: 24698233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of minimum contrast media volumes during percutaneous coronary intervention for chronic total occlusion lesion.
    Ebisawa S; Tanaka H; Muramatsu T; Kishi K; Oikawa Y; Muto M; Okada H; Kawasaki T; Yoshikawa R; Hamazaki Y; Tsuchikane E
    Heart Vessels; 2023 Sep; 38(9):1108-1116. PubMed ID: 37310464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Kurtul A; Yarlioglues M; Murat SN; Demircelik MB; Acikgoz SK; Ergun G; Duran M; Cetin M; Ornek E
    Angiology; 2015 May; 66(5):433-40. PubMed ID: 24834929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial success rate of percutaneous coronary intervention for chronic total occlusion in a native coronary artery is decreased in patients who underwent previous coronary artery bypass graft surgery.
    Teramoto T; Tsuchikane E; Matsuo H; Suzuki Y; Ito T; Ito T; Habara M; Nasu K; Kimura M; Kinoshita Y; Terashima M; Asakura Y; Matsubara T; Suzuki T
    JACC Cardiovasc Interv; 2014 Jan; 7(1):39-46. PubMed ID: 24456717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.